Therefore, tumour MLH1 methylation testing is used as the routine diagnostics testing to differentiate sporadic MLH1 methylated CRCs from inherited MLH1-deficient CRC caused by germline pathogenic variants (Lynch syndrome) [10, 11]. The gene discussed is MLH1; the disease is colorectal carcinoma.